Interactions between SIVNef, SIVGagPol and Alix correlate with viral replication and progression to AIDS in rhesus macaques

Virology

Volumn 394, Issue 1, 2009, Pages 47-56

  Jesus da Costa, Luciana ^a   Lopes dos Santos, Adriana ^a   Mandic, Robert ^b   Shaw, Karen ^c   Santana de Aguiar, Renato ^a,d   Tanuri, Amilcar ^a   Luciw, Paul A ^c   Peterlin, B Matija ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alix; Disease progression; GagPol; HIV; Monkey infection; Nef; Pathogenesis; SIV

Indexed keywords

ALIX PROTEIN; GAG PROTEIN; GAGPOL PROTEIN; NEF PROTEIN; POLYPROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM-BINDING PROTEINS; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, NEF; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD; VIRUS REPLICATION;

MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 70350125373     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.024     Document Type: Article

References (48)

1. Beissinger M., Paulus C., Bayer P., Wolf H., Rosch P., and Wagner R. Sequence-specific resonance assignments of the 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6. Eur. J. Biochem. 237 2 (1996) 383-392
2. Bentham M., Mazaleyrat S., and Harris M. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J. Gen. Virol. 87 Pt 3 (2006) 563-571
3. Brenner M., Munch J., Schindler M., Wildum S., Stolte N., Stahl-Hennig C., Fuchs D., Matz-Rensing K., Franz M., Heeney J., Ten Haaft P., Swigut T., Hrecka K., Skowronski J., and Kirchhoff F. Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques. J. Virol. 80 9 (2006) 4469-4481
4. Brugger B., Krautkramer E., Tibroni N., Munte C.E., Rauch S., Leibrecht I., Glass B., Breuer S., Geyer M., Krausslich H.G., Kalbitzer H.R., Wieland F.T., and Fackler O.T. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology 4 (2007) 70
5. Chakrabarti L.A., Metzner K.J., Ivanovic T., Cheng H., Louis-Virelizier J., Connor R.I., and Cheng-Mayer C. A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication. J. Virol. 77 2 (2003) 1245-1256
6. Costa L.J., Chen N., Lopes A., Aguiar R.S., Tanuri A., Plemenitas A., and Peterlin B.M. Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology 3 (2006) 33
7. Costa L.J., Zheng Y.H., Sabotic J., Mak J., Fackler O.T., and Peterlin B.M. Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1. J. Virol. 78 10 (2004) 5311-5323
8. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., and Desrosiers R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258 5090 (1992) 1938-1941
9. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D.A., Greenway A.L., Ellett A., Chatfield C., Lawson V.A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J.S., Cunningham A., Dwyer D., Dowton D., and Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270 5238 (1995) 988-991
10. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 18 (2000) 8358-8367
11. Fisher R.D., Chung H.Y., Zhai Q., Robinson H., Sundquist W.I., and Hill C.P. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128 5 (2007) 841-852
12. Geyer M., Fackler O.T., and Peterlin B.M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2 7 (2001) 580-585
13. Geyer M., Fackler O.T., and Peterlin B.M. Subunit H of the V-ATPase involved in endocytosis shows homology to beta-adaptins. Mol. Biol. Cell. 13 6 (2002) 2045-2056
14. Goldsmith M.A., Warmerdam M.T., Atchison R.E., Miller M.D., and Greene W.C. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69 7 (1995) 4112-4121
15. Higgins J.R., Sutjipto S., Marx P.A., and Pedersen N.C. Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates. J. Med. Primatol. 21 5 (1992) 265-269
16. Hill M.K., Shehu-Xhilaga M., Crowe S.M., and Mak J. Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability. J. Virol. 76 22 (2002) 11245-11253
17. Iafrate A.J., Carl S., Bronson S., Stahl-Hennig C., Swigut T., Skowronski J., and Kirchhoff F. Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J. Virol. 74 21 (2000) 9836-9844
18. Kaminchik J., Margalit R., Yaish S., Drummer H., Amit B., Sarver N., Gorecki M., and Panet A. Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Res. Hum. Retroviruses 10 8 (1994) 1003-1010
19. Kestler III H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 4 (1991) 651-662
20. Kimpton J., and Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66 4 (1992) 2232-2239
21. Kirchhoff F., Easterbrook P.J., Douglas N., Troop M., Greenough T.C., Weber J., Carl S., Sullivan J.L., and Daniels R.S. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J. Virol. 73 7 (1999) 5497-5508
22. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332 4 (1995) 228-232
23. Leiherer A., Ludwig C., and Wagner R. Influence of extended mutations of the HIV-1 transframe protein p6 on Nef-dependent viral replication and infectivity in vitro. Virology 378 1 (2009) 200-210
24. Lock M., Greenberg M.E., Iafrate A.J., Swigut T., Muench J., Kirchhoff F., Shohdy N., and Skowronski J. Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis. EMBO J. 18 10 (1999) 2722-2733
25. Ludwig C., Leiherer A., and Wagner R. Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation. J. Virol. 82 9 (2008) 4573-4584
26. Mandic R., Fackler O.T., Geyer M., Linnemann T., Zheng Y.H., and Peterlin B.M. Negative factor from SIV binds to the catalytic subunit of the V-ATPase to internalize CD4 and to increase viral infectivity. Mol. Biol. Cell. 12 2 (2001) 463-473
27. Marthas M.L., Ramos R.A., Lohman B.L., Van Rompay K.K., Unger R.E., Miller C.J., Banapour B., Pedersen N.C., and Luciw P.A. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J. Virol. 67 10 (1993) 6047-6055
28. Martin-Serrano J., Zang T., and Bieniasz P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7 12 (2001) 1313-1319
29. Miller M.D., Feinberg M.B., and Greene W.C. The HIV-1 nef gene acts as a positive viral infectivity factor. Trends Microbiol. 2 8 (1994) 294-298
30. Miller M.D., Warmerdam M.T., Gaston I., Greene W.C., and Feinberg M.B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179 1 (1994) 101-113
31. Munch J., Janardhan A., Stolte N., Stahl-Hennig C., Ten Haaft P., Heeney J.L., Swigut T., Kirchhoff F., and Skowronski J. T-cell receptor:CD3 down-regulation is a selected in vivo function of simian immunodeficiency virus Nef but is not sufficient for effective viral replication in rhesus macaques. J. Virol. 76 23 (2002) 12360-12364
32. Munch J., Rajan D., Schindler M., Specht A., Rucker E., Novembre F.J., Nerrienet E., Muller-Trutwin M.C., Peeters M., Hahn B.H., and Kirchhoff F. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J. Virol. 81 24 (2007) 13852-13864
33. Pandori M.W., Fitch N.J., Craig H.M., Richman D.D., Spina C.A., and Guatelli J.C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70 7 (1996) 4283-4290
34. Platt E.J., Wehrly K., Kuhmann S.E., Chesebro B., and Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72 4 (1998) 2855-2864
35. Saksela K., Cheng G., and Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14 3 (1995) 484-491
36. Sandrin V., and Cosset F.L. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J. Biol. Chem. 281 1 (2006) 528-542
37. Sawai E.T., Hamza M.S., Ye M., Shaw K.E., and Luciw P.A. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef. J. Virol. 74 4 (2000) 2038-2045
38. Schiavoni I., Trapp S., Santarcangelo A.C., Piacentini V., Pugliese K., Baur A., and Federico M. HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase of HIV-1 infectivity. J. Biol. Chem. 279 22 (2004) 22996-23006
39. Schwartz O., Marechal V., Le Gall S., Lemonnier F., and Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2 3 (1996) 338-342
40. Shacklett B.L., Shaw K.E., Adamson L.A., Wilkens D.T., Cox C.A., Montefiori D.C., Gardner M.B., Sonigo P., and Luciw P.A. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251. J. Virol. 76 22 (2002) 11365-11378
41. Strack B., Calistri A., Craig S., Popova E., and Gottlinger H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114 6 (2003) 689-699
42. Stumptner-Cuvelette P., Morchoisne S., Dugast M., Le Gall S., Raposo G., Schwartz O., and Benaroch P. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U. S. A. 98 21 (2001) 12144-12149
43. Wagner R., Graf M., Bieler K., Wolf H., Grunwald T., Foley P., and Uberla K. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum. Gene Ther. 11 17 (2000) 2403-2413
44. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., and Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46 6 (2002) 1896-1905
45. Welker R., Kottler H., Kalbitzer H.R., and Krausslich H.G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219 1 (1996) 228-236
46. Zhai Q., Fisher R.D., Chung H.Y., Myszka D.G., Sundquist W.I., and Hill C.P. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 15 1 (2008) 43-49
47. Zheng Y.H., Plemenitas A., Fielding C.J., and Peterlin B.M. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc. Natl. Acad. Sci. U. S. A. 100 14 (2003) 8460-8465
48. Zhou J., Yuan X., Dismuke D., Forshey B.M., Lundquist C., Lee K.H., Aiken C., and Chen C.H. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J. Virol. 78 2 (2004) 922-929